|
|
|
|
|
|
Collaborations and Studies
Because a better understanding of HIV drug resistance is key to managing the problem,
Monogram actively collaborates with leading academic institutions to conduct numerous
clinical studies and publish their results. The findings from these collaborations
provide insights into the mechanisms of resistance, the impact of mutations on
susceptibility, resistance to new classes of drugs, the choice of assays for the
evaluation of resistance, and the value of new technologies such as replication
capacity and co-receptor tropism.
We are proud to collaborate with leading research groups, some of which are listed
here:
Stanford University
University of California, San Francisco
University of California, San Diego
University of California, Davis
University of Alabama, Birmingham
University of Massachusetts
Massachusetts General Hospital
Tufts University
Duke University
University of North Carolina, Chapel Hill
University of Edinburgh
Catholic University, Rome
Studies and Abstracts
To view clinical data from some of our recent research collaborations, please select
from the following links:
|
|
 |
|
